Post-operative adhesions are an almost invariable consequence of abdominal or pelvic surgery, no matter whether this is performed by the open or laparoscopic technique. Their most important morbidity is small bowel obstruction, but other sequelae include female infertility and dyspareunia, and increased risk of visceral injury at any subsequent laparotomy or laparoscopy. Whether chronic abdominal pain is truly a consequence of adhesions is still a matter of some discussion, but it is likely to be accepted as an entity both by patients and by their legal advisors.
Introduction
Adhesions and their associated complications are of rising medico-legal interest, particularly given that they are now considered the most frequent complication of abdominopelvic surgery. 1, 2 To date, however, apart from our earlier reviews of the subject little has been published. 3, 4 This review seeks to provide a timely and important update given recent calls for action and consensus position on adhesions and their prevention.
1,2
Adhesions a problem after all surgery
Post-operative adhesions are an almost invariable consequence of abdominal or pelvic surgery, no matter whether this is performed by the open or laparoscopic technique. An incidence of 93% was found in an analysis of relaparotomy patients 5 and while laparoscopic surgery has been considered to be less adhesiogenic, particularly in the development of de novo adhesions, 6-8 a metaanalysis revealed comparable results for open vs laparoscopic surgery. 9 The environment, pressure and duration of the pneumoperitoneum are all considered important, 10 as is the surgeon's training. As Parker recently postulated, there is also a need to focus on planned surgery and, if secondary pathology is identified, to question the risk benefit of doing more than absolutely needed, as many of the traumas that cause adhesions are a routine part of surgery. 11 
Adhesions and the risks of subsequent surgery
Adhesions make further surgery difficult for the surgeon and carry important morbidity and mortality risks for the patient -as well as increasing healthcare system costs. In abdominal laparotomy through a pre-existing scar, 39% of patients experienced major complications including bowel obstruction, anastomotic leak, wound dehiscence, sepsis and pneumonia, with an overall mortality risk of 8%. Even in the hands of experienced surgeons, there was a 19% risk of inadvertent enterotomy, with a significantly higher need for parenteral nutrition, ICU admission and longer hospital stay, as well as an associated mortality of 13%.
12 A 10-25% risk of bowel injury has similarly been estimated in laparoscopic adhesiolysis. 13 Epidemiological research has shown that over a third of patients following initial abdominopelvic laparotomy were readmitted at a mean of 2.1 times over 10 years for problems related to adhesions or other abdominopelvic surgery potentially complicated by adhesions.
14 The consequential risk of adhesion-related problems in reoperative surgery is therefore considerable. In many cases, adhesions remain symptomless throughout lifehowever, if only a small percentage of patients develop complications, this amounts to a large number. A 44% lifetime risk of abdominal surgery has been estimated in US patients coming to post-mortem. 15 Patients with adhesions have a lifetime risk of developing clinical complications of adhesions. The most important of these is small bowel obstruction (SBO) with serious morbidity as well as a 10% risk of mortality. 16 The SCAR study of adhesion-related readmissions following general surgical or gynaecological laparotomy identified that 5.5% of readmissions were for surgical or non-operative treatment of SBO over the 10-year study period.
14 This rose to 7.1% following colorectal surgery. Surgery on the colon, rectum, ovaries and Fallopian tubes were shown to present the greatest risk. 17, 18 Further work by the SCAR study panel demonstrated that the comparative risk of adhesion-related complications following open and laparoscopic gynaecological surgery was similar. 19 Additionally in colorectal surgery, the SCAR panel has investigated the comparative risk after specific procedures and demonstrated that panproctocolectomy, total colectomy and ileostomy surgery carry the highest risk of adhesion-related readmission. 20 Recent work by Duron and colleagues has shown that early post-operative mortality is strongly influenced by age and comorbidities but long-term mortality by post-operative complications which include inadvertent enterotomy. 21 Other important sequelae include female infertility and dyspareunia. Adhesions have also been identified as the most common pathology in 40% of cases of chronic pelvic pain (CPP) which is a major gynaecological problem and a difficult and costly disorder to treat. 22, 23 While there is mounting evidence for an association with CPP, 24 whether this is a true consequence of the adhesions is still a matter of some debate, but it is likely to be accepted as an entity both by patients and by their legal advisors. The consequences and complications of peritoneal adhesions have recently been comprehensively reviewed by Harry van Goor. 25 
Adhesion-related medico-legal considerations
There is a rising concern in the UK at the cost of medico-legal claims in general with an estimated reserve of potential of cases against the UK National Health Service amounting to some £12 billion. 26 As adhesions are now considered the most frequent complication of abdominopelvic surgery 1,2 they will likely also attract rising medico-legal interest. Possible medico-legal consequences of adhesions include:
Failure to diagnose the problem Adhesive intestinal obstruction Inadvertent enterotomy at subsequent laparotomy or laparoscopy Chronic abdominal pain/dyspareunia Infertility Glove powder granulomas related to use of starch-powdered gloves Failure to use precautions to prevent adhesions
Adhesion-related claims
With the assistance of the Medical Protection Society (MPS) and the National Health Service Litigation Authority (NHSLA), we have assessed recent adhesion-related claims. The MPS was formed over 110 years ago and is a leading provider of comprehensive professional indemnity and expert advice with over 250,000 members worldwide. In the UK, it largely handles claims in the private medical sector and primary care. The NHSLA was formed in 1995 as a Special Health Authority (part of the National Health Service), responsible for handling negligence claims made against NHS bodies in England.
In As medico-legal adviser at the MPS, Dr Jane Cowan undertook a review of case files opened from 2001 onwards that had ''adhesions'' or similar key words in the case headline. The cases were initially either complaints or claims. While the key word searches will probably not pick up all relevant cases of adhesions, the review provides a useful snapshot with which to look at adhesion-related clinical negligence claims in the private sector in the UK.
Sixteen cases related to post-operative abdominal adhesions were found. There were four cases involving 5-16-year olds against general practitioners for failure/delay in diagnosis of appendicitis leading to peritonitis and subsequent formation/risk of adhesions. Only one of these cases was upheld; the three others were rejected. The remaining 12 cases were all adult female patients, at least five of which were as a result of adhesions from previous gynaecological surgery. Five of the complaints were against GPs for alleged delays in diagnosing problems (including intestinal obstruction) occurring as a result of adhesions. The remaining seven complaints were against surgeons. These cases comprised:
Two cases of adhesions as a result of laparoscopic surgery complications:
B Transection of the common bile duct B Bowel perforation One allegation of negligence:
B Bladder perforated during adhesiolysis One allegation regarding the operative management of adhesions rather than the cause of them One case where adhesions were part of a wider complaint on surgical management One allegation against a surgeon some 21 years previously: B The medical notes were able to demonstrate that the technique employed was not negligent. One case related to post-operative complications following adhesiolysis:
B 10 years of adhesions symptoms following gynaecological surgery led to the adhesiolysis operation.
Of these cases, only one was upheld with a small financial settlement made. The numbers and outcomes of claims against the MPS in the period 2001-2007 were not dissimilar to those previously reported in the period 1989-1999. 3 In the period 2001-2007, cases within the NHS were handled by the more recently formed NHSLA. The NHSLA database is used essentially for claims management purposes. There are acknowledged weaknesses, for example when a claim is closed the database is not always updated to show why the case was upheld. With the assistance of the NHSLA Risk Management team, an assessment of the claims related to adhesions was undertaken by searching free fields in their claims database for ''adhesions'' as a key element of the claim. This may underestimate the incidence of adhesionrelated problems in medico-legal claims. However, as with the findings from the MPS, it provides a useful snapshot. While the NHSLA advise that less than 4% of all claims they receive go to court, and most of those are because they relate to minors and so need court approval, the NHSLA as a Public body publish all their cost data and thus the data provided by them includes out of court as well as court settlements.
In Of the 41 gynaecology claims, 28 were related to injuries to related organs and structures and included three deaths (Table 1) . Amongst the 41 gynaecological claims, five related to consent issues of which three resulted in successful claims. Four cases also resulted in infertility of which two were successful with two currently open.
Amongst the 26 general surgery claims 12 related to injuries to organs and structures and also included three deaths ( Table 2) . Eleven of these have been settled, seven successfully with only one remaining open. There were nine claims that involved issues relating to delay in diagnosis/treatment, one including a death, and four cases that involved consent issues.
Of the 57 closed claims the 29 successful claims resulted in a settlement of over £3.3 million (Table 3) . Noting recent concerns about the size of the NHSLA legal bills, 26 lawyers' costs alone accounted for over one-third of the total payouts for the successful claims.
The issue of negligence
The key question that needs to be considered is whether these medico-legal negligence claims were avoidable.
To establish negligence, the claimant has to establish:
There is a duty of care There has been a breach in the duty of care This breach caused the injury.
All three aspects need to be present and demonstrated for negligence to be established. The Health Act 1999 also now establishes that all clinicians have a Duty of Quality.
27
In terms of negligence, a doctor's duty of care includes giving careful advice and sufficient information, upon which the patient could then reach a decision as to whether to accept or refuse treatment. In negligence cases, patients often claim that insufficient information was provided and that, if it had been provided, consent would not have been granted. While for many years the Bolam test of negligence had been used as the precedent in determining negligence, recently judgements are more likely to be made in favour of what reasonable patients might expect from what reasonable doctors might do. 28 As a result of the Chester vs Afshar case, in which a patient was not warned of the risk of neurological damage, the NHSLA issued formal guidance which identified a level of 1-2% as being the limit above which failure of notification could be deemed to be negligent. 29 What is usually overlooked by surgeons is that the risk of adhesions has now been clearly demonstrated to be above this 2% risk threshold and, indeed, above the risks of many other problems that are already routinely discussed as part of the consent process (Table 4) . 30, 31 Therefore, surgeons who do not mention adhesions during the consent process could be putting themselves at risk of potential negligence claims if problems then ensue.
Reducing the risk of adhesions
Given the amount of evidence of the risk of adhesions and increasing evidence that adopting adhesion-reduction strategies is likely to reduce this risk, surgeons need to: All these principles are largely common sense, particularly given the volume of evidence on adhesions and their complications. Importantly they are simple and specific principles now enshrined Table 5 not only to avoid the risk of medicolegal claims but, most importantly, to provide the best chance of improving patients' outcomes.
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